| 000 | 03224nam a2200313Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625140622.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-9931 | ||
| 245 | 1 | 0 | _aPharmaceutical prerequisites for a multi-target therapy |
| 490 | 0 | _vPhytoMedicine, 13(1), p.12-19, 2006 | |
| 520 | 3 | _aThe quality of a phytomedicine is defined by the quality of the herbal drug, the manufacturing of the drug preparations and the properties of the finished product, taking into account the special requirements of the individual herbal species in accordance with Good Manufacturing Practice (GMP)standards [2003. Medicinal Products for Human and Veterinary Use. Eudralex, vol. 4 (2003/94/EC)]. The quality control of the complete process is based on pharmacognostic methods, characteristic fingerprint chromatograms, defined amounts of marker substances, physicochemical characteristics and microbiological monitoring. For a herbal multi-component preparation used in multi-target therapy, these pharmaceutical prerequisites have to be ensured for all components and for their combination, as is exemplified by Iberogasts (STW 5)a fixed combination of hydroethanolic extracts of bitter candytuft (Iberis amara), angelica root (Angelicae radix), milk thistle fruit (Silybi mariani fructus), celandine herb (Chelidonii herba), caraway fruit (Carvi fructus), liquorice root (Liquiritiae radix), peppermint herb (Menthae piperitae folium), balm leaf (Melissae folium)and chamomile flower (Matricariae flos)using in the therapy of gastrointestinal compliants (Ro¨ sch et al., 2006). The prerequisites for the quality of each of its components according to actual standards are at first the cultivation of the plant material according to the Guidelines for Good Agricultural Practice (GAP)conditions of Medicinal and Aromatic Plants [1998. Z. Arzn. Gew. Pfl. 3, 166-178]to yield a defined raw material of high quality. Characteristic compounds of the extracts had to be identified and different analytical methods such as HPLC, with low coefficients of variation had to be developed to analyze each of the standardized ethanolic extracts and the finished product. At the example of the extract of I. amara these necessary investigations are described. The variability of the plant material in its natural habitats, the identification of characteristic compounds and exemplary chromatograms for fingerprint evaluation and quantification are shown. These data are required for characterization of the profile of the active substances in the finished product. | |
| 650 | 1 | 4 | _aHERBAL MULTI-COMPONENT PRODUCT |
| 650 | 1 | 4 | _aIBERIS AMARA |
| 650 | 1 | 4 | _aIBEROGASTS |
| 650 | 1 | 4 | _aSTW 5 |
| 650 | 1 | 4 | _aQUALITY CONTROL |
| 650 | 1 | 4 | _aTLC FINGERPRINT |
| 650 | 1 | 4 | _aGLC AND HPLC |
| 650 | 1 | 4 | _aMETHODS |
| 650 | 1 | 4 | _aMARKER SUBSTANCES |
| 650 | 1 | 4 | _aKAEMPFEROL-3,40-DI-O-B-GLUCOPYRANOSIDE-7-O-B-RHAMNOPYRANOSIDE |
| 650 | 1 | 4 | _aCUCURBITACINS |
| 700 | 1 | 2 | _aKroll, U. |
| 700 | 1 | 2 | _aCordes, C. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1Qf_56nNow7ioMZbgGbPeb-sagJJJbry7/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c44174 _d44174 |
||